Achillion Investor Seeks To Halt $930M Pharma Tie-Up
An Achillion Pharmaceuticals Inc. stockholder has filed suit in Delaware federal court to halt the company's proposed $930 million merger with Alexion Pharmaceuticals Inc., asserting that not enough financial information has...To view the full article, register now.
Already a subscriber? Click here to view full article